NRx Pharmaceuticals, Inc.
USD0.01
+0.00 (+0.00%)
CEO
Jonathan C. Javitt
IPO Date
2017-12-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.00
52W High
$0.16
Market Cap
$0.00B
| 200,000 |
| $0.32 |
| 14 Feb 2023 | Javitt Jonathan C | — | Disposed | 0 | $0.00 |
| 19 Dec 2022 | VAN VOORHEES SETH | director: CHIEF FINANCIAL OFFICER | P-Purchase | Acquired | 30,000 | $1.10 |
| 19 Dec 2022 | VAN VOORHEES SETH | director: CHIEF FINANCIAL OFFICER | P-Purchase | Acquired | 7,021 | $1.11 |
| 19 Dec 2022 | VAN VOORHEES SETH | director: CHIEF FINANCIAL OFFICER | P-Purchase | Acquired | 600 | $1.10 |
| 19 Dec 2022 | VAN VOORHEES SETH | director: CHIEF FINANCIAL OFFICER | P-Purchase | Acquired | 8,716 | $1.12 |
| 9 Dec 2022 | Javitt Jonathan C | director | S-Sale | Disposed | 400,000 | $1.00 |
| 28 Nov 2022 | VAN VOORHEES SETH | director: CHIEF FINANCIAL OFFICER | P-Purchase | Acquired | 7,021 | $1.11 |
| 28 Nov 2022 | VAN VOORHEES SETH | director: CHIEF FINANCIAL OFFICER | P-Purchase | Acquired | 600 | $1.10 |